Navigation Links
Using Drugs as Weapons can Never Be 'non Lethal', Say Doctors

In a report [Thursday, 24 May 2007] the BMA says it is extremely concerned at the growing interest of world governments in using drugs in law enforcement situations, in the belief that these can be non lethal.

The use of drugs as weapons1, produced by the BMAs Board of Science, concludes that it is impossible to deliver the right drug in the right dose to the right individuals in a way that is both effective and does not cause significant deaths. The report highlights the Moscow theatre siege of October 2002 the Russian authorities said a derivative of the drug fentanyl2 was delivered through the air-conditioning system to end the siege. This killed over 130 hostages.

Dr Vivienne Nathanson, BMA Head of Science and Ethics, said: It is important to remember that target groups are likely to comprise people of varying weights, sizes and ages; some may be pregnant or have pre-existing medical conditions. It is virtually impossible to control the amount of a drug delivered or to ensure it acts without producing toxic effects or causing death.

It is disingenuous of governments to describe drugs as non-lethal there is no difference between a drug and a poison except the dose. Using drugs as a method of law enforcement may constitute a violation of international conventions which prohibit the use of chemical weapons. This is of great concern to the BMA.

The BMA is keen to alert doctors to the fact that medical knowledge may be called upon for the development of drugs as weapons, as well as antidotes and treatments. Future advances in drug development may spawn more sophisticated and sinister agents that may not be limited to science fiction.

Key recommendations from the report state that organizations that represent healthcare professionals should:

Advocate a multidisciplinary input to policy-making about all weapons and their use in relation to international law or arms control and disar mament, international humanitarian law and human rights law.

Ensure that governments and policy-makers in military and law enforcement agencies who may be considering the use of drugs as weapons understand the fundamental scientific, legal and ethical considerations surrounding such use.

Work to promote the norms prohibiting the use of poisons, and therefore the Biological and Toxin Weapons Convention [BTWC] and the Chemical Weapons Convention [CWC]. They should further promote understanding that the use of drugs as weapons would violate such norms.

Advocate that, in the event of those states which are party to the CWC deciding that drugs can be used for law enforcement; these states declare the types and quantities of such agents.

Ensure that the consequences of the use of drugs as weapons for military purposes are considered as part of the review of such weapons required by international humanitarian law.

Advocate against the use of drugs as weapons and not be involved in the training of military or law enforcement personnel in the administration of drugs as weapons.

Recognise the complex ethical dilemmas raised by research on, development of, planning for and use of drugs as weapons and promote professional debate on these matters.

Develop guidelines for any healthcare professional involved in research and the development of agents, materials or knowledge that might be put to a dual use.

Ensure that the pharmaceutical industry is alert to the possibility that their research and products might be put to malign use, and work with them to prevent this.

Encourage their members to abide by professional codes that prohibit involvement in development of dual use technologies or materials.


'"/>




Related medicine news :

1. Preventing Strokes Using Less Invasive Techniques
2. Using Cholesterol Lowering Drugs Effectively
3. Using herbal remedies with chemotherapy may not be a good idea
4. Teenagers Using Hormones And Dietary Supplements To Good Physique
5. Using Stem Cells To Treat Incontinence In Women
6. Using Eyes As The Line Of Reference For Fetal Brain Imaging
7. Remote Robotic Surgery Using Miniature Robots
8. Driving While Using A Mobile Phone May Be Dangerous
9. Detecting Brain Abnormalities in Babies Using New Brain Scanners.
10. Mobilizing Stem Cells at the Injured Site Using Hyperbaric Oxygen Treatments.
11. Treatment of Sickle Cell Anemia Using Gene Therapy.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, ... University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) ... program, developed in association with efforts by the American College of Surgeons, U.S. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... laboratory instruments are critical to ensuring high-quality results and maintaining GMP and USP ... of Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... 28, 2017 , ... With less than 10,000 dermatologists in the United States ... be limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... customer online, today released its inaugural survey on the State of Acne in America. ...
(Date:3/28/2017)... ... , ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio ... country to sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National ... helped propel the clinic from a small start-up to number 78 in the country ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... , March 28, 2017 ... research with Cambridge ... Consortium   The Milner Therapeutics Institute today announces ... Elysium Health has committed significant investment for collaborative projects with ... next four years. This is the first major research investment ...
(Date:3/27/2017)... TEL-AVIV, Israel , March 27, 2017 /PRNewswire/ ... TASE: THXBY), a specialty clinical-stage pharmaceutical company specializing in the ... of its public offering in the ... Shares (ADSs), each ADS representing 40 ordinary shares ... per ADS. In addition, Therapix has granted the ...
Breaking Medicine Technology: